Evidence map›Paper›PMID 20617193›Full record

Trial reportPloS one2010

Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region.

José L Burgos, Julia A Gaebler, Steffanie A Strathdee, Remedios Lozada, Hugo Staines, Thomas L Patterson

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00338845 (Safer Sex Intervention for At-risk Women in Mexico), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00338845 phase2completednot on this map

Safer Sex Intervention for At-risk Women in Mexico

TypeinterventionalSponsorUniversity of California, San DiegoRan2003 to 2008Enrolled1,800ConditionsHIV Infections, Sexually Transmitted DiseasesArmsShare Safer Sex program, Standard didactic safer-sex counseling program
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. HIV Treatment and Prevention: A Simple Model to Determine Optimal Investment.Medical decision making : an international journal of the Society for Medical Decision Making · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.European journal of nuclear medicine and molecular imaging · 2012
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

José L BurgosDivision of Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Julia A Gaebler
Steffanie A Strathdee
Remedios Lozada
Hugo Staines
Thomas L Patterson
University of California, San Diego · USUniversidad Autónoma de Ciudad Juárez · MXXochicalco University · MX

Funding

Intervention for Female Workers in MexicoR01MH065849 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PATTERSON, THOMAS L. · 2004 to 2008
$3.6M
Epidemiologic Study on Changing HIV Risks Among FSW-IDUs on the Mexico-US BorderR01DA023877 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2012
$3.3M
The Role of Economic Evaluation in Translating HIV/AIDS Behavioral InterventionsK01MH095680 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURGOS, JOSE LUIS · 2012 to 2016
$902k
NIDA NIH HHS R01 DA023877NIMH NIH HHS K01 MH095680NIMH NIH HHS R01 MH065849
6 · The paper itself

Abstract

backgroundPrevious research demonstrated efficacy of a brief behavioral intervention to reduce incidence of HIV and sexually transmitted infections (STIs) among female sex workers (FSWs) in Tijuana and Ciudad Juarez, Mexico, cities on Mexico's border with the US. We assessed this intervention's cost-effectiveness. METHODOLOGY AND PRINCIPAL

findingsA life-time Markov model was developed to estimate HIV cases prevented, changes in quality-adjusted life expectancy (QALE), and costs per additional quality-adjusted life year gained (QALY), comparing (in US$2,009) no intervention to a once-only and annual intervention. Future costs and health benefits were discounted annually at 3%. Sensitivity analyses evaluated model robustness. We found that for a hypothetical 1,000 FSWs receiving the once-only intervention, there were 33 HIV cases prevented and 5.7 months of QALE gained compared to no intervention. The additional cost per QALY gained was US$183. For FSWs receiving the intervention annually, there were 29 additional HIV cases prevented and 4.5 additional months of QALE compared to the once-only intervention. The additional cost per QALY was US$1,075. When highly active antiretroviral therapy (HAART) was included in the model, the annual intervention strategy resulted in net savings and dominated both once-only and no intervention strategies, and remained robust across extensive sensitivity analyses. Even when considering clinical benefits from HAART, ignoring added costs, the cost per QALY gained remained below three times the Mexican GDP per capita, and below established cost-effectiveness thresholds. CONCLUSIONS/SIGNIFICANCE: This brief intervention was shown to be cost-effective among FSWs in two Mexico-US border cities and may have application for FSWs in other resource-limited settings.

trial registrationClinicalTrials.gov NCT00338845.

Indexed as

Sex WorkAntiretroviral Therapy, Highly ActiveCalibrationCondomsCost-Benefit AnalysisFemaleHIV InfectionsHumansLife ExpectancyMarkov ChainsMexicoSexually Transmitted DiseasesSubstance-Related DisordersUnited States

Identifiers

PMID20617193
PMCPMC2894974
OpenAlexW1967672627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.